NCT00014456View on ClinicalTrials.gov

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

March 31, 2000

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
Bladder CancerBreast CancerCarcinoma of Unknown PrimaryEsophageal CancerGastric CancerHead and Neck CancerLung CancerMelanoma (Skin)Ovarian CancerPancreatic CancerProstate CancerSarcoma
Interventions
BIOLOGICAL

filgrastim

DRUG

docetaxel

DRUG

gemcitabine hydrochloride

Trial Locations (1)

03756-0002

Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT00014456 - Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter